Summary
Stereotactic core biopsy is becoming increasingly popular as a technique which provides a histologic diagnosis for mammographic abnormalities while avoiding the trauma, deformity, and much of the cost associated with surgical biopsy. This review evaluates the published literature on the diagnostic accuracy of core biopsy for ductal carcinoma in situ and invasive breast cancer and the ability of core biopsy to characterize malignant lesions sufficiently to allow treatment planning. Issues of cost effectiveness are examined in the context of the degree of suspicion of the mammographic abnormality being sampled by core technique as well as subsequent breast cancer therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Shapiro S, Venet W, Strax P, Venet L: Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1968–1986. Johns Hopkins University Press, Baltimore, 1988.
Tabar L, Fagerberg G, Duffy S, Day, NE, Gad A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30:187–210, 1992.
Verbeek KA, Hendriks J, Holland R, Mravunac M, Sturmans F, Day NE: Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project 1975–1981. Lancet i:1222–1224, 1984.
Nystrom L, Rutqvist L, Wall S: Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 341:973–978, 1993.
Dawson D, Thompson G: Breast cancer risk factors and screening: United States, 1987 (DHHS Publication No. PHS 90-1500). U.S. Government Printing Office, Washington DC, 1990.
Hall FM, Storella JM, Silverstone DZ, Wyshak G: Nonpalpable breast lesions. Recommendations for biopsy based on suspicion of carcinoma at mammography. Radiology 167:353–358, 1988.
Crylak D: Induced costs of low-cost screening mammography. Radiology 168:661–663. 1988.
Eddy D: Screening for breast cancer. Ann Int Med 1111:389–399, 1989.
Parker SH, Burbank F, Jackman RL, Aucreman CJ, Cardenosa G, Cink TM, Coscia JL, Eklund GW, Evans WP, Garver PR, Gramm HF, Haas DK, Jacob KM, Kelly KM, Killebrew LK, Lechner MC, Perlman SJ, Smid AP, Tabar L, Taber FE, Wynn RT: Percutaneous large-core breast biopsy: A multi-institutional study. Radiology 193:359–364, 1994.
Bolmgren J, Jacobsen B, Nordenstrom B: Stereotactic instrument for needle biopsy of the mamma. Am J Roentgenol 129:121–125, 1977.
Lofgren M, Andersson I, Bondeson L, Lindholm K: X-ray guided fine-needle aspiration for the cytologic diagnosis of nonpalpable breast lesions. Cancer 61: 1032–1037, 1988.
Azavedo E, Svane G, Auer G: Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet i:1033–1036, 1989.
Hann L, Ducatman BS, Wang HH, Fein V, McIntire JM: Non-palpable breast lesions: Evaluation by means of fine-needle aspiration cytology. Radiology 171:373–376, 1989.
Ciatto S, Del Turco MR, Bravetti P: Non-palpable breast lesions: Stereotactic fine-needle aspiration cytology. Radiology 173:57–59, 1989.
Dent DM, Kirkpatrick AE, McGoogan E, Chetty U, Anderson TJ: Stereotaxic localisation and aspiration cytology in impalpable breast lesions. Clinical Radiology 40:380–382, 1989.
Dowlatshahi K, Gent JY, Schmidt R, Jokich PM, Bibbo M, Sprenger E: Non-palpable breast tumors: Diagnosis with stereotaxic localization and fine-needle aspiration. Radiology 170:427–433, 1989.
Fajardo LL, Davis JR, Wiens JL, Trego DC: Mammographically-guided stereotactic fine-needle aspiration cytology of non-palpable breast lesions: Prospective comparison with surgical biopsy results. Am J Roentgenol 155:977–981, 1990.
Helvie MA, Baker DE, Adler DD, Andersson I, Naylor B, Buckwalter KA: Radiographically guided fine-needle aspiration of non-palpable breast lesions. Radiology 174:657–661, 1990.
Schmidt R, Morrow M, Bibbo M, Cox S: Benefits of stereotactic aspiration cytology. Administrative Radiology 9:35–42, 1990.
Lofgren M, Andersson I, Lindholm K: Stereotactic fine-needle aspiration for cytologic diagnosis of non-palpable breast lesions. Am J Roentgenol 154:1191–1195, 1990.
Mitnick JS, Vazquez MF, Roses DF, Harris MN, Gianutsos R, Waisman J: Stereotaxic localization for fine-needle aspiration breast biopsy: Initial experience with 300 patients. Arch Surg 126: 1137–1140, 1991.
Parker SH, Lovin JD, Jobe WE, Luethke JM, Hopper KD, Yakes WF, Burke BJ: Stereotactic breast biopsy with a biopsy gun. Radiology 176: 741–747, 1990.
Schmidt RA: Stereotactic breast biopsy. CA 44:172–191, 1994.
Dowlatshahi K, Yaremko L, Kluskens LF, Jokich PM: Nonpalpable breast lesions: Findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology. Radiology 181:745–750, 1991.
Dronkers DJ: Stereotaxic core biopsy of breast lesions. Radiology 183:631–634, 1992.
Parker SH, Lovin JD, Jobe WE, Burke BJ, Hopper KD, Yakes WF: Nonpalpable breast lesions: Stereotactic automated large-core biopsies. Radiology 180:403–407, 1991.
Mikhail RA, Nathan RC, Weiss M, Tummala RM, Mullangi UR, Lawrence L, Mukkamala AR: Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy. Ann Surg Oncol 18:353–367, 1994.
Gisvold JJ, Goellner JR, Grant CS, Donohue JH, Sykes MW, Karsell PR, Coffey SL, Jung S: Breast biopsy: A comparative study of stereotaxically guided core and excisional techniques. Am J Radiol 162:815–820, 1994.
Elvecrog EL, Lechner MC, Nelson MT: Nonpalpable breast lesions: Correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 188:453–455, 1993.
Morrow M, Schmidt R, Cregger B, Hassett C, Cox S: Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies. Arch Surg 129:1091–1096, 1994.
Silverstein M, Gamagani P, Colburn WJ, Gierson ED, Rosser RJ, Handel N, Waisman JR: Nonpalpable breast lesions: Diagnosis with slightly overpenetrated screen film mammography and hook wire-directed biopsy in 1914 cases. Radiology 171:633–638, 1989.
Wilhelm MC, Edge S, Cole D, DeParedes E, Frierson HF: Nonpalpable invasive breast cancer. Ann Surg 213:600–605, 1991.
Burbank F, Belville J: Core breast biopsy, research, and what not to do. Radiology 185:639–644, 1992.
Jackson VP, Reynolds HE: Stereotaxic needle-core biopsy and fine-needle aspiration cytologic evaluation of nonpalpable breast lesions. Radiology 181:633–634, 1991.
Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE: Stereotaxic 14-gauge breast biopsy: How many core biopsy specimens are needed? Radiology 192:793–795, 1994.
Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA: Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with cancer or atypical hyperplasia. Radiology 193:91–95, 1994.
Dupont W, Page D: Risk factors for breast cancer in women with proliferative disease. N Engl J Med 312: 146–151, 1985.
Rubin E, Visscher D, Alexander R, Urist M, Maddox WA: Proliferative disease and atypia in biopsies performed for nonpalpable lesions directed mammographically. Cancer 61:2077–2082, 1988.
Morrow M, Schnitt S, Harris JR: Ductal carcinoma in situ.In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. JB Lippincott, Philadelphia, 1995 (in press).
Kopans DB: Review of stereotaxic large-core needle biopsy and surgical biopsy results in nonpalpable breast lesions. Radiology 189:665–666, 1993.
Homer MJ, Smith TJ, Safaii H: Pre-biopsy needle localization: methods, problems, and expected results. Radiol Clin North Am 30:139–153, 1992.
Norton L, Zeligman B, Pearlman N: Accuracy and cost of needle localization breast biopsy. Arch Surg 123: 947–950, 1988.
Helvie MA, Pennes DR, Rebner M, Adler DD: Mammographic follow-up of low-suspicion lesions: Compliance rate and diagnostic yield. Radiology 178:155–158, 1991.
Liberman L, Dershaw DD, Rosen PP, Giess CS, Cohen MA, Abramson AF, Hann LE: Stereotaxic core biopsy of breast carcinoma: Accuracy at predicting invasion. Radiology 194:379–381, 1995.
Sacchini V, Luini A, Agresti R, Galimberti V, Rilke F, Greco M: Nonpalpable breast lesions. Analysis of 952 operated cases. Breast Cancer Res Treat 32:59, 1995
Hernandez LE, Connelly PJ, Strickler SA, Akers MM, Dunn MM: Are stereotaxic breast biopsies adequate? Surgery 115:610–615, 1994.
Holland R, Hendriks JHCL: Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation. Sem Diag Pathol 11: 181–192, 1994.
Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JHCL, Verbeek ALM, Schnitt SJ, Silver B, Boyages J, Harris JR: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8:113–118, 1990.
Sickles EA: Periodic mammographic follow-up of probably benign lesions: Results in 3,184 consecutive cases. Radiology 179:463–468, 1991.
Datoc PD, Hayes CE, Conway WF, Bosch HA, Neal MP: Mammographic follow-up of nonpalpable low-suspicion breast abnormalities: One versus two views. Radiology 180:387–391, 1991.
Varas X, Leborgne F, Leborgne JH: Nonpalpable, probably benign lesions: Role of follow-up mammography. Radiology 184:409–414, 1992.
Evans WP: Stereotactic breast biopsy.In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. JB Lippincott, Philadelphia, 1995 (in press).
Kearney T, Morrow M: The need for reexcision does not adversely affect the success of breast conserving therapy. Ann Surg Oncol 1995 (in press).
Harris JR, Morrow M: The local therapy of breast cancer.In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. JB Lippincott, Philadelphia, 1995 (in press).
Author information
Authors and Affiliations
Additional information
Presented in part at the 17th Annual San Antonio Breast Cancer Symposium.
Rights and permissions
About this article
Cite this article
Morrow, M. When can stereotactic core biopsy replace excisional biopsy? — A clinical perspective. Breast Cancer Res Tr 36, 1–9 (1995). https://doi.org/10.1007/BF00690179
Issue Date:
DOI: https://doi.org/10.1007/BF00690179